The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLVIII.ab

Guillain-Barré (or GB-like) syndrome (w/wo ARF)

Publications

Lahoz Fernandez PE, Miranda Pereira J, Fonseca Risso I, Baleeiro Rodrigues Silva P, Freitas Barboza IC, Vieira Silveira CG, Diogo Silva G, Marzorati Kuntz Puglia P, Genaro Mutarelli E

Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.

Acta neurologica Scandinavica 2021 Dec 29;; — 2021 Dec 29

Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, Trojano M

Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?

Clinical neurology and neurosurgery 2021 Aug 13;208;106887 — 2021 Aug 13 — 106887